Loading...
Remdesivir for COVID-19: Evidence review of the clinical benefits and harm
Blockman, M Cohen, K De Waal, R Gray, A Kredo, T Maartens, G Nel, J Parrish, A Rees, H Reubenson, G
Blockman, M
Cohen, K
De Waal, R
Gray, A
Kredo, T
Maartens, G
Nel, J
Parrish, A
Rees, H
Reubenson, G
Citations
Altmetric:
Abstract
Description
Date
2020-06-24
Journal Title
Journal ISSN
Volume Title
Publisher
South African National Department of Health
Collections
Files
Loading...
Remdesivir for COVID-19
Adobe PDF, 654.7 KB
Research Projects
Organizational Units
Journal Issue
Keywords
Remdesivir, Remdesivir for COVID-19, Prodrug, Antiviral, Clinical review, Pharmacology
Citation
Blockman M, Cohen K, De Waal R, Gray A, et al. Remdesivir for COVID-19: evidence review of the clinical benefits and harm. South African National Department of Health, 2020.
License
Attribution 3.0 United States